Details
Category: Volume 05 Issue 09 September 2017
Hits: 1569

Title: Evaluation of Brain Changes in Alzheimer disease Using MRI

Authors: Inaam Mohamed, Mohammed Yousef, Ahmed Abukonna

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i9.103

Abstract

Alzheimer’s disease (AD) is a multifaceted disease in which cumulative pathological brain insults result in progressive cognitive decline that ultimately leads to dementia. The aim of this article was to evaluate the structural MRI changes in AD, focusing particularly on atrophy in typical late-onset of AD. Also to identify other promising biomarkers that can set structural loss in the broader context of functional changes at different stages of the disease.

The study was conducted in Sudan, 302 subjects were enrolled (200 Male and 102 female).All subjects underwent thorough clinical and cognitive assessments at the time of their MRI scans.MRI studies were performed on 1.5 Tesla Toshiba whole body MR systems using standard imaging head coil. Routine brain MRI was performed in 3 orthogonal planes, including at least T1, T2, and fluid-attenuated inversion recovery (FLAIR) weighted images.

The result of the study revealed that age is the most important risk factor for Alzheimer disease (AD) because it is independently linked to brain atrophy, the common affected age group (70 – 80) years, particularly more than 80 years. The generalized atrophy has been observed in 78.1% of the cases. Furthermore, ventricular enlargement was seen in 65% of the cases.

Structural MRI markers now support earlier and more-precise diagnosis and measurement of progression. The presences of atrophy as well as ventricular changes are a partially validated marker for early diagnosis of the disease.

Keywords: Alzheimer’s disease, MRI, Brain Atrophy, Cerebral Ventricles.

 

References

  1. APOSTOLOVA, L. G., GREEN, A. E., BABAKCHANIAN, S., HWANG, K. S., CHOU, Y.-Y., TOGA, A. W. & THOMPSON, P. M. 2012. Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment and Alzheimer's disease. Alzheimer Dis Assoc Disord, 26, 17.
  2. JACK, C. R., BERNSTEIN, M. A., FOX, N. C., THOMPSON, P., ALEXANDER, G., HARVEY, D., BOROWSKI, B., BRITSON, P. J., L WHITWELL, J. & WARD, C. 2008. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods. Journal of magnetic resonance imaging, 27, 685-691.
  3. KLUNK, W. E., ENGLER, H., NORDBERG, A., WANG, Y., BLOMQVIST, G., HOLT, D. P., BERGSTRÖM, M., SAVITCHEVA, I., HUANG, G. F. & ESTRADA, S. 2004. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐ Annals of neurology, 55, 306-319.
  4. NESTOR, S. M., RUPSINGH, R., BORRIE, M., SMITH, M., ACCOMAZZI, V., WELLS, J. L., FOGARTY, J., BARTHA, R. & INITIATIVE, A. S. D. N. 2008. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain, 131, 2443-2454.
  5. PRINS, N. D. & VAN SWIETEN, J. C. 2010. Alzheimer disease: MRI and CSF biomarkers in AD--accuracy and temporal change. Nat Rev Neurol, 6, 650-1.
  6. RAJI, C. A., LOPEZ, O. L., KULLER, L. H., CARMICHAEL, O. T. & BECKER, J. T. 2009. Age, Alzheimer disease, and brain structure. Neurology, 73, 1899-905.
  7. RIDHA, B. H., BARNES, J., BARTLETT, J. W., GODBOLT, A., PEPPLE, T., ROSSOR, M. N. & FOX, N. C. 2006. Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. The Lancet Neurology, 5, 828-834.
  8. SELKOE, D., MANDELKOW, E. & HOLTZMAN, D. 2012. Deciphering alzheimer disease. Cold Spring Harbor perspectives in medicine, 2, a011460.
  9. TERRY, R. D., MASLIAH, E., SALMON, D. P., BUTTERS, N., DETERESA, R., HILL, R., HANSEN, L. A. & KATZMAN, R. 1991. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Annals of neurology, 30, 572-580.
  10. THOMPSON, P. M., HAYASHI, K. M., DE ZUBICARAY, G., JANKE, A. L., ROSE, S. E., SEMPLE, J., HERMAN, D., HONG, M. S., DITTMER, S. S. & DODDRELL, D. M. 2003. Dynamics of gray matter loss in Alzheimer's disease. Journal of neuroscience, 23, 994-1005.
  11. VEMURI, P. & JACK, C. R. 2010. Role of structural MRI in Alzheimer's disease. Alzheimer's research & therapy, 2, 23.
  12. VEMURI, P., WHITWELL, J. L., KANTARCI, K., JOSEPHS, K. A., PARISI, J. E., SHIUNG, M. S., KNOPMAN, D. S., BOEVE, B. F., PETERSEN, R. C. & DICKSON, D. W. 2008. Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage. Neuroimage, 42, 559-567.

Corresponding Author

Inaam Mohamed

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.